• レポートコード:QY2207E09208 • 出版社/出版日:QYResearch / 2022年7月 • レポート形態:英文、PDF、108ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療 |
Single User | ¥735,000 (USD4,900) | ▷ お問い合わせ |
Multi User | ¥1,102,500 (USD7,350) | ▷ お問い合わせ |
Enterprise License | ¥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のブラシュコ線治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にブラシュコ線治療の世界市場のxxx%を占める「レチノイド外用剤」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。 中国のブラシュコ線治療の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのブラシュコ線治療市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのブラシュコ線治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。 ブラシュコ線治療のグローバル主要メーカーには、GlaxoSmithKline、Novartis AG、Sanofi、Johnson & Johnson、Endo International、Purdue Pharma、Boehringer Ingelheim International GmbH、Dr. Reddy's Laboratories、Hisamitsu Pharmaceutical、Bristol-Myers Squibb Company、Mylan N.V.、Bayer AGなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。 ブラシュコ線治療市場は、種類と用途によって区分されます。世界のブラシュコ線治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 レチノイド外用剤、ステロイド外用剤、その他 【用途別セグメント】 病院、在宅医療、専門クリニック 【掲載地域】 北米:アメリカ、カナダ ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米:メキシコ、ブラジル、アルゼンチン 中東・アフリカ:トルコ、サウジアラビア、UAE 【目次(一部)】 ・調査の範囲 - ブラシュコ線治療製品概要 - 種類別市場(レチノイド外用剤、ステロイド外用剤、その他) - 用途別市場(病院、在宅医療、専門クリニック) - 調査の目的 ・エグゼクティブサマリー - 世界のブラシュコ線治療販売量予測2017-2028 - 世界のブラシュコ線治療売上予測2017-2028 - ブラシュコ線治療の地域別販売量 - ブラシュコ線治療の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ブラシュコ線治療販売量 - 主要メーカー別ブラシュコ線治療売上 - 主要メーカー別ブラシュコ線治療価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模(レチノイド外用剤、ステロイド外用剤、その他) - ブラシュコ線治療の種類別販売量 - ブラシュコ線治療の種類別売上 - ブラシュコ線治療の種類別価格 ・用途別市場規模(病院、在宅医療、専門クリニック) - ブラシュコ線治療の用途別販売量 - ブラシュコ線治療の用途別売上 - ブラシュコ線治療の用途別価格 ・北米市場 - 北米のブラシュコ線治療市場規模(種類別、用途別) - 主要国別のブラシュコ線治療市場規模(アメリカ、カナダ) ・ヨーロッパ市場 - ヨーロッパのブラシュコ線治療市場規模(種類別、用途別) - 主要国別のブラシュコ線治療市場規模(ドイツ、フランス、イギリス、イタリア、ロシア) ・アジア太平洋市場 - アジア太平洋のブラシュコ線治療市場規模(種類別、用途別) - 主要国別のブラシュコ線治療市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア) ・中南米市場 - 中南米のブラシュコ線治療市場規模(種類別、用途別) - 主要国別のブラシュコ線治療市場規模(メキシコ、ブラジル、アルゼンチン) ・中東・アフリカ市場 - 中東・アフリカのブラシュコ線治療市場規模(種類別、用途別) - 主要国別のブラシュコ線治療市場規模(トルコ、サウジアラビア) ・企業情報 GlaxoSmithKline、Novartis AG、Sanofi、Johnson & Johnson、Endo International、Purdue Pharma、Boehringer Ingelheim International GmbH、Dr. Reddy's Laboratories、Hisamitsu Pharmaceutical、Bristol-Myers Squibb Company、Mylan N.V.、Bayer AG ・産業チェーン及び販売チャネル分析 - ブラシュコ線治療の産業チェーン分析 - ブラシュコ線治療の原材料 - ブラシュコ線治療の生産プロセス - ブラシュコ線治療の販売及びマーケティング - ブラシュコ線治療の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ブラシュコ線治療の産業動向 - ブラシュコ線治療のマーケットドライバー - ブラシュコ線治療の課題 - ブラシュコ線治療の阻害要因 ・主な調査結果 |
Blaschko’s lines are the growth lines of the skin (Blaschko’s line), which are the growth lines of the skin (Blaschko’s line). Under normal circumstances, the lines that extend the human body cannot be seen, which leads to the appearance of the reverse glyph Lesions, in the appearance of the shape and shape of the lesions, there will be no strip-shaped lesions of various shapes, the head is a strip-shaped lesion, and it is a lesion of various shapes.
Market Analysis and Insights: Global Blaschko’s Lines Treatment Market
The global Blaschko’s Lines Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Topical Retinoid accounting for % of the Blaschko’s Lines Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Blaschko’s Lines Treatment market size is valued at US$ million in 2021, while the North America and Europe Blaschko’s Lines Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Blaschko’s Lines Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Blaschko’s Lines Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Blaschko’s Lines Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Blaschko’s Lines Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Blaschko’s Lines Treatment market.
Global Blaschko’s Lines Treatment Scope and Market Size
Blaschko’s Lines Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Blaschko’s Lines Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Topical Retinoid
Topical Steroid
Others
Segment by Application
Hospitals
Homecare
Specialty Clinics
By Company
GlaxoSmithKline
Novartis AG
Sanofi
Johnson & Johnson
Endo International
Purdue Pharma
Boehringer Ingelheim International GmbH
Dr. Reddy’s Laboratories
Hisamitsu Pharmaceutical
Bristol-Myers Squibb Company
Mylan N.V.
Bayer AG
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blaschko’s Lines Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Topical Retinoid
1.2.3 Topical Steroid
1.2.4 Others
1.3 Market by Application
1.3.1 Global Blaschko’s Lines Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Blaschko’s Lines Treatment Market Perspective (2017-2028)
2.2 Blaschko’s Lines Treatment Growth Trends by Region
2.2.1 Blaschko’s Lines Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Blaschko’s Lines Treatment Historic Market Size by Region (2017-2022)
2.2.3 Blaschko’s Lines Treatment Forecasted Market Size by Region (2023-2028)
2.3 Blaschko’s Lines Treatment Market Dynamics
2.3.1 Blaschko’s Lines Treatment Industry Trends
2.3.2 Blaschko’s Lines Treatment Market Drivers
2.3.3 Blaschko’s Lines Treatment Market Challenges
2.3.4 Blaschko’s Lines Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blaschko’s Lines Treatment Players by Revenue
3.1.1 Global Top Blaschko’s Lines Treatment Players by Revenue (2017-2022)
3.1.2 Global Blaschko’s Lines Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Blaschko’s Lines Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blaschko’s Lines Treatment Revenue
3.4 Global Blaschko’s Lines Treatment Market Concentration Ratio
3.4.1 Global Blaschko’s Lines Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blaschko’s Lines Treatment Revenue in 2021
3.5 Blaschko’s Lines Treatment Key Players Head office and Area Served
3.6 Key Players Blaschko’s Lines Treatment Product Solution and Service
3.7 Date of Enter into Blaschko’s Lines Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blaschko’s Lines Treatment Breakdown Data by Type
4.1 Global Blaschko’s Lines Treatment Historic Market Size by Type (2017-2022)
4.2 Global Blaschko’s Lines Treatment Forecasted Market Size by Type (2023-2028)
5 Blaschko’s Lines Treatment Breakdown Data by Application
5.1 Global Blaschko’s Lines Treatment Historic Market Size by Application (2017-2022)
5.2 Global Blaschko’s Lines Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Blaschko’s Lines Treatment Market Size (2017-2028)
6.2 North America Blaschko’s Lines Treatment Market Size by Type
6.2.1 North America Blaschko’s Lines Treatment Market Size by Type (2017-2022)
6.2.2 North America Blaschko’s Lines Treatment Market Size by Type (2023-2028)
6.2.3 North America Blaschko’s Lines Treatment Market Share by Type (2017-2028)
6.3 North America Blaschko’s Lines Treatment Market Size by Application
6.3.1 North America Blaschko’s Lines Treatment Market Size by Application (2017-2022)
6.3.2 North America Blaschko’s Lines Treatment Market Size by Application (2023-2028)
6.3.3 North America Blaschko’s Lines Treatment Market Share by Application (2017-2028)
6.4 North America Blaschko’s Lines Treatment Market Size by Country
6.4.1 North America Blaschko’s Lines Treatment Market Size by Country (2017-2022)
6.4.2 North America Blaschko’s Lines Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Blaschko’s Lines Treatment Market Size (2017-2028)
7.2 Europe Blaschko’s Lines Treatment Market Size by Type
7.2.1 Europe Blaschko’s Lines Treatment Market Size by Type (2017-2022)
7.2.2 Europe Blaschko’s Lines Treatment Market Size by Type (2023-2028)
7.2.3 Europe Blaschko’s Lines Treatment Market Share by Type (2017-2028)
7.3 Europe Blaschko’s Lines Treatment Market Size by Application
7.3.1 Europe Blaschko’s Lines Treatment Market Size by Application (2017-2022)
7.3.2 Europe Blaschko’s Lines Treatment Market Size by Application (2023-2028)
7.3.3 Europe Blaschko’s Lines Treatment Market Share by Application (2017-2028)
7.4 Europe Blaschko’s Lines Treatment Market Size by Country
7.4.1 Europe Blaschko’s Lines Treatment Market Size by Country (2017-2022)
7.4.2 Europe Blaschko’s Lines Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blaschko’s Lines Treatment Market Size (2017-2028)
8.2 Asia-Pacific Blaschko’s Lines Treatment Market Size by Type
8.2.1 Asia-Pacific Blaschko’s Lines Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Blaschko’s Lines Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Blaschko’s Lines Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Blaschko’s Lines Treatment Market Size by Application
8.3.1 Asia-Pacific Blaschko’s Lines Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Blaschko’s Lines Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Blaschko’s Lines Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Blaschko’s Lines Treatment Market Size by Region
8.4.1 Asia-Pacific Blaschko’s Lines Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Blaschko’s Lines Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Blaschko’s Lines Treatment Market Size (2017-2028)
9.2 Latin America Blaschko’s Lines Treatment Market Size by Type
9.2.1 Latin America Blaschko’s Lines Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Blaschko’s Lines Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Blaschko’s Lines Treatment Market Share by Type (2017-2028)
9.3 Latin America Blaschko’s Lines Treatment Market Size by Application
9.3.1 Latin America Blaschko’s Lines Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Blaschko’s Lines Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Blaschko’s Lines Treatment Market Share by Application (2017-2028)
9.4 Latin America Blaschko’s Lines Treatment Market Size by Country
9.4.1 Latin America Blaschko’s Lines Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Blaschko’s Lines Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blaschko’s Lines Treatment Market Size (2017-2028)
10.2 Middle East & Africa Blaschko’s Lines Treatment Market Size by Type
10.2.1 Middle East & Africa Blaschko’s Lines Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Blaschko’s Lines Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Blaschko’s Lines Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Blaschko’s Lines Treatment Market Size by Application
10.3.1 Middle East & Africa Blaschko’s Lines Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Blaschko’s Lines Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Blaschko’s Lines Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Blaschko’s Lines Treatment Market Size by Country
10.4.1 Middle East & Africa Blaschko’s Lines Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Blaschko’s Lines Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Blaschko’s Lines Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Blaschko’s Lines Treatment Business (2017-2022)
11.1.5 GlaxoSmithKline Recent Developments
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Blaschko’s Lines Treatment Introduction
11.2.4 Novartis AG Revenue in Blaschko’s Lines Treatment Business (2017-2022)
11.2.5 Novartis AG Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Blaschko’s Lines Treatment Introduction
11.3.4 Sanofi Revenue in Blaschko’s Lines Treatment Business (2017-2022)
11.3.5 Sanofi Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Blaschko’s Lines Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Blaschko’s Lines Treatment Business (2017-2022)
11.4.5 Johnson & Johnson Recent Developments
11.5 Endo International
11.5.1 Endo International Company Details
11.5.2 Endo International Business Overview
11.5.3 Endo International Blaschko’s Lines Treatment Introduction
11.5.4 Endo International Revenue in Blaschko’s Lines Treatment Business (2017-2022)
11.5.5 Endo International Recent Developments
11.6 Purdue Pharma
11.6.1 Purdue Pharma Company Details
11.6.2 Purdue Pharma Business Overview
11.6.3 Purdue Pharma Blaschko’s Lines Treatment Introduction
11.6.4 Purdue Pharma Revenue in Blaschko’s Lines Treatment Business (2017-2022)
11.6.5 Purdue Pharma Recent Developments
11.7 Boehringer Ingelheim International GmbH
11.7.1 Boehringer Ingelheim International GmbH Company Details
11.7.2 Boehringer Ingelheim International GmbH Business Overview
11.7.3 Boehringer Ingelheim International GmbH Blaschko’s Lines Treatment Introduction
11.7.4 Boehringer Ingelheim International GmbH Revenue in Blaschko’s Lines Treatment Business (2017-2022)
11.7.5 Boehringer Ingelheim International GmbH Recent Developments
11.8 Dr. Reddy’s Laboratories
11.8.1 Dr. Reddy’s Laboratories Company Details
11.8.2 Dr. Reddy’s Laboratories Business Overview
11.8.3 Dr. Reddy’s Laboratories Blaschko’s Lines Treatment Introduction
11.8.4 Dr. Reddy’s Laboratories Revenue in Blaschko’s Lines Treatment Business (2017-2022)
11.8.5 Dr. Reddy’s Laboratories Recent Developments
11.9 Hisamitsu Pharmaceutical
11.9.1 Hisamitsu Pharmaceutical Company Details
11.9.2 Hisamitsu Pharmaceutical Business Overview
11.9.3 Hisamitsu Pharmaceutical Blaschko’s Lines Treatment Introduction
11.9.4 Hisamitsu Pharmaceutical Revenue in Blaschko’s Lines Treatment Business (2017-2022)
11.9.5 Hisamitsu Pharmaceutical Recent Developments
11.10 Bristol-Myers Squibb Company
11.10.1 Bristol-Myers Squibb Company Company Details
11.10.2 Bristol-Myers Squibb Company Business Overview
11.10.3 Bristol-Myers Squibb Company Blaschko’s Lines Treatment Introduction
11.10.4 Bristol-Myers Squibb Company Revenue in Blaschko’s Lines Treatment Business (2017-2022)
11.10.5 Bristol-Myers Squibb Company Recent Developments
11.11 Mylan N.V.
11.11.1 Mylan N.V. Company Details
11.11.2 Mylan N.V. Business Overview
11.11.3 Mylan N.V. Blaschko’s Lines Treatment Introduction
11.11.4 Mylan N.V. Revenue in Blaschko’s Lines Treatment Business (2017-2022)
11.11.5 Mylan N.V. Recent Developments
11.12 Bayer AG
11.12.1 Bayer AG Company Details
11.12.2 Bayer AG Business Overview
11.12.3 Bayer AG Blaschko’s Lines Treatment Introduction
11.12.4 Bayer AG Revenue in Blaschko’s Lines Treatment Business (2017-2022)
11.12.5 Bayer AG Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Blaschko’s Lines Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Topical Retinoid
Table 3. Key Players of Topical Steroid
Table 4. Key Players of Others
Table 5. Global Blaschko’s Lines Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Blaschko’s Lines Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Blaschko’s Lines Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Blaschko’s Lines Treatment Market Share by Region (2017-2022)
Table 9. Global Blaschko’s Lines Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Blaschko’s Lines Treatment Market Share by Region (2023-2028)
Table 11. Blaschko’s Lines Treatment Market Trends
Table 12. Blaschko’s Lines Treatment Market Drivers
Table 13. Blaschko’s Lines Treatment Market Challenges
Table 14. Blaschko’s Lines Treatment Market Restraints
Table 15. Global Blaschko’s Lines Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Blaschko’s Lines Treatment Revenue Share by Players (2017-2022)
Table 17. Global Top Blaschko’s Lines Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blaschko’s Lines Treatment as of 2021)
Table 18. Ranking of Global Top Blaschko’s Lines Treatment Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Blaschko’s Lines Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Blaschko’s Lines Treatment Product Solution and Service
Table 22. Date of Enter into Blaschko’s Lines Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Blaschko’s Lines Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Blaschko’s Lines Treatment Revenue Market Share by Type (2017-2022)
Table 26. Global Blaschko’s Lines Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Blaschko’s Lines Treatment Revenue Market Share by Type (2023-2028)
Table 28. Global Blaschko’s Lines Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Blaschko’s Lines Treatment Revenue Share by Application (2017-2022)
Table 30. Global Blaschko’s Lines Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Blaschko’s Lines Treatment Revenue Share by Application (2023-2028)
Table 32. North America Blaschko’s Lines Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Blaschko’s Lines Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Blaschko’s Lines Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Blaschko’s Lines Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Blaschko’s Lines Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Blaschko’s Lines Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Blaschko’s Lines Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Blaschko’s Lines Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Blaschko’s Lines Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Blaschko’s Lines Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Blaschko’s Lines Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Blaschko’s Lines Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Blaschko’s Lines Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Blaschko’s Lines Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Blaschko’s Lines Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Blaschko’s Lines Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Blaschko’s Lines Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Blaschko’s Lines Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Blaschko’s Lines Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Blaschko’s Lines Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Blaschko’s Lines Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Blaschko’s Lines Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Blaschko’s Lines Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Blaschko’s Lines Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Blaschko’s Lines Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Blaschko’s Lines Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Blaschko’s Lines Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Blaschko’s Lines Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Blaschko’s Lines Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Blaschko’s Lines Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 62. GlaxoSmithKline Company Details
Table 63. GlaxoSmithKline Business Overview
Table 64. GlaxoSmithKline Blaschko’s Lines Treatment Product
Table 65. GlaxoSmithKline Revenue in Blaschko’s Lines Treatment Business (2017-2022) & (US$ Million)
Table 66. GlaxoSmithKline Recent Developments
Table 67. Novartis AG Company Details
Table 68. Novartis AG Business Overview
Table 69. Novartis AG Blaschko’s Lines Treatment Product
Table 70. Novartis AG Revenue in Blaschko’s Lines Treatment Business (2017-2022) & (US$ Million)
Table 71. Novartis AG Recent Developments
Table 72. Sanofi Company Details
Table 73. Sanofi Business Overview
Table 74. Sanofi Blaschko’s Lines Treatment Product
Table 75. Sanofi Revenue in Blaschko’s Lines Treatment Business (2017-2022) & (US$ Million)
Table 76. Sanofi Recent Developments
Table 77. Johnson & Johnson Company Details
Table 78. Johnson & Johnson Business Overview
Table 79. Johnson & Johnson Blaschko’s Lines Treatment Product
Table 80. Johnson & Johnson Revenue in Blaschko’s Lines Treatment Business (2017-2022) & (US$ Million)
Table 81. Johnson & Johnson Recent Developments
Table 82. Endo International Company Details
Table 83. Endo International Business Overview
Table 84. Endo International Blaschko’s Lines Treatment Product
Table 85. Endo International Revenue in Blaschko’s Lines Treatment Business (2017-2022) & (US$ Million)
Table 86. Endo International Recent Developments
Table 87. Purdue Pharma Company Details
Table 88. Purdue Pharma Business Overview
Table 89. Purdue Pharma Blaschko’s Lines Treatment Product
Table 90. Purdue Pharma Revenue in Blaschko’s Lines Treatment Business (2017-2022) & (US$ Million)
Table 91. Purdue Pharma Recent Developments
Table 92. Boehringer Ingelheim International GmbH Company Details
Table 93. Boehringer Ingelheim International GmbH Business Overview
Table 94. Boehringer Ingelheim International GmbH Blaschko’s Lines Treatment Product
Table 95. Boehringer Ingelheim International GmbH Revenue in Blaschko’s Lines Treatment Business (2017-2022) & (US$ Million)
Table 96. Boehringer Ingelheim International GmbH Recent Developments
Table 97. Dr. Reddy's Laboratories Company Details
Table 98. Dr. Reddy's Laboratories Business Overview
Table 99. Dr. Reddy's Laboratories Blaschko’s Lines Treatment Product
Table 100. Dr. Reddy's Laboratories Revenue in Blaschko’s Lines Treatment Business (2017-2022) & (US$ Million)
Table 101. Dr. Reddy's Laboratories Recent Developments
Table 102. Hisamitsu Pharmaceutical Company Details
Table 103. Hisamitsu Pharmaceutical Business Overview
Table 104. Hisamitsu Pharmaceutical Blaschko’s Lines Treatment Product
Table 105. Hisamitsu Pharmaceutical Revenue in Blaschko’s Lines Treatment Business (2017-2022) & (US$ Million)
Table 106. Hisamitsu Pharmaceutical Recent Developments
Table 107. Bristol-Myers Squibb Company Company Details
Table 108. Bristol-Myers Squibb Company Business Overview
Table 109. Bristol-Myers Squibb Company Blaschko’s Lines Treatment Product
Table 110. Bristol-Myers Squibb Company Revenue in Blaschko’s Lines Treatment Business (2017-2022) & (US$ Million)
Table 111. Bristol-Myers Squibb Company Recent Developments
Table 112. Mylan N.V. Company Details
Table 113. Mylan N.V. Business Overview
Table 114. Mylan N.V. Blaschko’s Lines Treatment Product
Table 115. Mylan N.V. Revenue in Blaschko’s Lines Treatment Business (2017-2022) & (US$ Million)
Table 116. Mylan N.V. Recent Developments
Table 117. Bayer AG Company Details
Table 118. Bayer AG Business Overview
Table 119. Bayer AG Blaschko’s Lines Treatment Product
Table 120. Bayer AG Revenue in Blaschko’s Lines Treatment Business (2017-2022) & (US$ Million)
Table 121. Bayer AG Recent Developments
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Blaschko’s Lines Treatment Market Share by Type: 2021 VS 2028
Figure 2. Topical Retinoid Features
Figure 3. Topical Steroid Features
Figure 4. Others Features
Figure 5. Global Blaschko’s Lines Treatment Market Share by Application: 2021 VS 2028
Figure 6. Hospitals Case Studies
Figure 7. Homecare Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Blaschko’s Lines Treatment Report Years Considered
Figure 10. Global Blaschko’s Lines Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Blaschko’s Lines Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Blaschko’s Lines Treatment Market Share by Region: 2021 VS 2028
Figure 13. Global Blaschko’s Lines Treatment Market Share by Players in 2021
Figure 14. Global Top Blaschko’s Lines Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blaschko’s Lines Treatment as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Blaschko’s Lines Treatment Revenue in 2021
Figure 16. North America Blaschko’s Lines Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Blaschko’s Lines Treatment Market Size Market Share by Type (2017-2028)
Figure 18. North America Blaschko’s Lines Treatment Market Size Market Share by Application (2017-2028)
Figure 19. North America Blaschko’s Lines Treatment Market Size Share by Country (2017-2028)
Figure 20. United States Blaschko’s Lines Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Blaschko’s Lines Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Blaschko’s Lines Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Blaschko’s Lines Treatment Market Size Market Share by Type (2017-2028)
Figure 24. Europe Blaschko’s Lines Treatment Market Size Market Share by Application (2017-2028)
Figure 25. Europe Blaschko’s Lines Treatment Market Size Share by Country (2017-2028)
Figure 26. Germany Blaschko’s Lines Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Blaschko’s Lines Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Blaschko’s Lines Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Blaschko’s Lines Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Blaschko’s Lines Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Blaschko’s Lines Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Blaschko’s Lines Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Blaschko’s Lines Treatment Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Blaschko’s Lines Treatment Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Blaschko’s Lines Treatment Market Size Share by Region (2017-2028)
Figure 36. China Blaschko’s Lines Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Blaschko’s Lines Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Blaschko’s Lines Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Blaschko’s Lines Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Blaschko’s Lines Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Blaschko’s Lines Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Blaschko’s Lines Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Blaschko’s Lines Treatment Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Blaschko’s Lines Treatment Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Blaschko’s Lines Treatment Market Size Share by Country (2017-2028)
Figure 46. Mexico Blaschko’s Lines Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Blaschko’s Lines Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Blaschko’s Lines Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Blaschko’s Lines Treatment Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Blaschko’s Lines Treatment Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Blaschko’s Lines Treatment Market Size Share by Country (2017-2028)
Figure 52. Turkey Blaschko’s Lines Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Blaschko’s Lines Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Blaschko’s Lines Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. GlaxoSmithKline Revenue Growth Rate in Blaschko’s Lines Treatment Business (2017-2022)
Figure 56. Novartis AG Revenue Growth Rate in Blaschko’s Lines Treatment Business (2017-2022)
Figure 57. Sanofi Revenue Growth Rate in Blaschko’s Lines Treatment Business (2017-2022)
Figure 58. Johnson & Johnson Revenue Growth Rate in Blaschko’s Lines Treatment Business (2017-2022)
Figure 59. Endo International Revenue Growth Rate in Blaschko’s Lines Treatment Business (2017-2022)
Figure 60. Purdue Pharma Revenue Growth Rate in Blaschko’s Lines Treatment Business (2017-2022)
Figure 61. Boehringer Ingelheim International GmbH Revenue Growth Rate in Blaschko’s Lines Treatment Business (2017-2022)
Figure 62. Dr. Reddy's Laboratories Revenue Growth Rate in Blaschko’s Lines Treatment Business (2017-2022)
Figure 63. Hisamitsu Pharmaceutical Revenue Growth Rate in Blaschko’s Lines Treatment Business (2017-2022)
Figure 64. Bristol-Myers Squibb Company Revenue Growth Rate in Blaschko’s Lines Treatment Business (2017-2022)
Figure 65. Mylan N.V. Revenue Growth Rate in Blaschko’s Lines Treatment Business (2017-2022)
Figure 66. Bayer AG Revenue Growth Rate in Blaschko’s Lines Treatment Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed